Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Investigation|August 14, 2018
CD28 blockade controls T cell activation to prevent graft-versus-host disease in primatesBenjamin K Watkins, Victor Tkachev, Scott N Furlan, et al.
Journal of Medical Primatology|October 30, 2009
Resources for genetic management and genomics research on non-human primates at the National Primate Research Centers (NPRCs)S Kanthaswamy, J P Capitanio, C J Dubay, et al.
Cancer Discovery|March 23, 2018
Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Nonhuman PrimatesAgne Taraseviciute, Victor Tkachev, Rafael Ponce, et al.
Blood|September 14, 2010
GVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28- CD8+ T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppressionWeston P Miller, Swetha Srinivasan, Angela Panoskaltsis-Mortari, et al.
Blood|March 6, 2024
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate-conditioned Fanconi anemia miceAsim Saha, Rahul Palchaudhuri, Leanne Lanieri, et al.
Blood|June 12, 2025
A single dose of a CD137 antibody-drug conjugate protects nonhuman primate allogeneic HCT recipients against acute GVHDUlrike Gerdemann, Kyle Kimler, Matthew R Warren, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 24, 2025
Multiomic Immune Profiling of Pediatric Transplant Recipients Identifies Cell States Associated with Vaccine ResponseJohannes Wedel, Ying Tang, Bayan Alsairafi, et al.
Bone Marrow Transplantation|February 21, 2024
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHDLev Gorfinkel, Sharmila Raghunandan, Benjamin Watkins, et al.
Transplantation and Cellular Therapy|April 7, 2024
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated ToxicitiesTakuto Takahashi, Benjamin Watkins, Brandi Bratrude, et al.
BMC Endocrine Disorders|September 21, 2018
Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and overR S Du Puy, I Postmus, D J Stott, et al.
Pageof 13